139 related articles for article (PubMed ID: 32322091)
1. Computer-aided synthesis of dapsone-phytochemical conjugates against dapsone-resistant Mycobacterium leprae.
Swain SS; Paidesetty SK; Dehury B; Das M; Vedithi SC; Padhy RN
Sci Rep; 2020 Apr; 10(1):6839. PubMed ID: 32322091
[TBL] [Abstract][Full Text] [Related]
2. Disease Burden and Current Therapeutical Status of Leprosy with Special Emphasis on Phytochemicals.
Swain SS; Sahoo G; Mahapatra PK; Panda SK
Curr Top Med Chem; 2022; 22(19):1611-1625. PubMed ID: 34503409
[TBL] [Abstract][Full Text] [Related]
3. Molecular docking and simulation study for synthesis of alternative dapsone derivative as a newer antileprosy drug in multidrug therapy.
Swain SS; Paidesetty SK; Dehury B; Sahoo J; Vedithi SC; Mahapatra N; Hussain T; Padhy RN
J Cell Biochem; 2018 Dec; 119(12):9838-9852. PubMed ID: 30125973
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous detection of Mycobacterium leprae and its susceptibility to dapsone using DNA heteroduplex analysis.
Williams DL; Pittman TL; Gillis TP; Matsuoka M; Kashiwabara Y
J Clin Microbiol; 2001 Jun; 39(6):2083-8. PubMed ID: 11376039
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and interactions of antileprosy drugs.
George J
Biochem Pharmacol; 2020 Jul; 177():113993. PubMed ID: 32339493
[TBL] [Abstract][Full Text] [Related]
6. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
Matsuoka M; Kashiwabara Y; Namisato M
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
[TBL] [Abstract][Full Text] [Related]
7. Dapsone resistance in Mycobacterium leprae.
Gillis TP; Williams DL
Lepr Rev; 2000 Dec; 71 Suppl():S91-5. PubMed ID: 11201896
[TBL] [Abstract][Full Text] [Related]
8. Study of rifampicin resistance and comparison of dapsone resistance of M. leprae in pre- and post-MDT era.
Gupta UD; Katoch K; Katoch VM
Indian J Lepr; 2009; 81(3):131-4. PubMed ID: 20509341
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a potential lead compound for treating leprosy with dapsone resistance mutation in M. leprae folP1.
Nisha J; Ramanathan K; Nawaz Khan F; Dhanasekaran D; Shanthi V
Mol Biosyst; 2016 Jun; 12(7):2178-88. PubMed ID: 27120972
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antileprosy activity of some dialkyldithiocarbamates.
Makarov V; Riabova OB; Yuschenko A; Urlyapova N; Daudova A; Zipfel PF; Möllmann U
J Antimicrob Chemother; 2006 Jun; 57(6):1134-8. PubMed ID: 16595643
[TBL] [Abstract][Full Text] [Related]
11. The infectivity of drug resistant cases.
Desai AC; Apte SN; Bhide MB
Lepr India; 1977 Jan; 49(1):54-8. PubMed ID: 330944
[TBL] [Abstract][Full Text] [Related]
12. Multiple docking analysis and
Halder ST; Dhorajiwala TM; Samant LR
Int J Mycobacteriol; 2019; 8(3):229-236. PubMed ID: 31512598
[TBL] [Abstract][Full Text] [Related]
13. In vivo activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with dapsone, against Mycobacterium leprae.
Dhople AM
Int J Antimicrob Agents; 2002 Jan; 19(1):71-4. PubMed ID: 11814771
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo activity of K-130, a dihydrofolate reductase inhibitor, against Mycobacterium leprae.
Dhople AM
Arzneimittelforschung; 1999 Mar; 49(3):267-71. PubMed ID: 10219472
[TBL] [Abstract][Full Text] [Related]
15. Mouse foot-pad studies with M. leprae--effect of desoxy fructo serotonin (DFS) and related compounds.
Balakrishnan S; Mester L; Venkataramaniah HN; Bhatia VN
Indian J Lepr; 1985; 57(2):323-8. PubMed ID: 3908578
[TBL] [Abstract][Full Text] [Related]
16. Primary dapsone resistance in Cebu, The Philippines; cause for concern.
dela Cruz E; Cellona RV; Balagon MV; Villahermosa LG; Fajardo TT; Abalos RM; Tan EV; Walsh GP
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):253-6. PubMed ID: 8862258
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae.
Dhople AM; Strong LC; Meindl W; Schoenenberger H; Gardner GD
Arzneimittelforschung; 1991 Mar; 41(3):253-6. PubMed ID: 1867663
[TBL] [Abstract][Full Text] [Related]
18. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
[TBL] [Abstract][Full Text] [Related]
19. Minimal inhibitory concentration of dapsone for Mycobacterium leprae in rats.
Peters JH; Gordon GR; Murray JF; Fieldsteel AH; Levy L
Antimicrob Agents Chemother; 1975 Nov; 8(5):551-7. PubMed ID: 1108776
[TBL] [Abstract][Full Text] [Related]
20. Molecular detection of multidrug-resistant Mycobacterium leprae from Indian leprosy patients.
Lavania M; Singh I; Turankar RP; Ahuja M; Pathak V; Sengupta U; Das L; Kumar A; Darlong J; Nathan R; Maseey A
J Glob Antimicrob Resist; 2018 Mar; 12():214-219. PubMed ID: 29097343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
